Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Kanghua Healthcare Group Co Buyback Yield % Chart
FRA:E9Q vs HCA, THC, DVA: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, Guangdong Kanghua Healthcare Group Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangdong Kanghua Healthcare Group Co Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Guangdong Kanghua Healthcare Group Co's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Guangdong Kanghua Healthcare Group Co's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) has a Buyback Yield % of 0.00 as of Jul. 28, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Guangdong Kanghua Healthcare Group Co and its competitors. According to the industry distribution chart, Guangdong Kanghua Healthcare Group Co ranks #999999 out of 276 companies in the Healthcare Providers & Services industry.
Is Guangdong Kanghua Healthcare Group Co's Buyback Yield % too high?
Guangdong Kanghua Healthcare Group Co's current Buyback Yield % is 0.00. Based on the distribution chart, Guangdong Kanghua Healthcare Group Co ranks #999999 out of 276 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Guangdong Kanghua Healthcare Group Co has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Guangdong Kanghua Healthcare Group Co's Buyback Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Guangdong Kanghua Healthcare Group Co ranks #999999 out of 276 companies for Buyback Yield %. This places Guangdong Kanghua Healthcare Group Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Guangdong Kanghua Healthcare Group Co and its competitors. Guangdong Kanghua Healthcare Group Co's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Kanghua Healthcare Group Co stock overvalued right now?
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) has a current Buyback Yield % of 0.00. The stock's GF Value™ is €0.22, compared to a current price of €0.19 — trading 15.5% below its estimated fair value. The current Buyback Yield % is 0.00. Guangdong Kanghua Healthcare Group Co's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Guangdong Kanghua Healthcare Group Co (FRA:E9Q), the current Buyback Yield % is 0.00 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangdong Kanghua Healthcare Group Co (FRA:E9Q) Overvalued in 2026?
Based on GuruFocus' analysis, Guangdong Kanghua Healthcare Group Co stock appears to be undervalued.
The current stock price of €0.19 is trading 15.5% below its estimated GF Value™ of €0.22.
Key valuation signals for FRA:E9Q:
Buyback Yield %: 0.00
GF Value™: €0.22 vs. price of €0.19 (15.5% below fair value)
No single metric tells the full story. See the FRA:E9Q stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangdong Kanghua Healthcare Group Co Business Description
Guangdong Kanghua Healthcare Group Co Ltd provides healthcare services. The reportable segments are as follows, The Hospital services segment, which generates majority revenue, includes the provision of hospital services including inpatient healthcare services, outpatient healthcare services, and physical examination services; Rehabilitation and other healthcare services including the provision of rehabilitation services; Elderly healthcare services include the provision of elderly healthcare services, including assisted living, adult daycare, longterm care, residential care and hospice care to the aged patients; and Haemodialysis services segment is principally engaged in the operation of haemodialysis outpatient centres. It generates all of its revenue from the PRC.
82GF Score
Get the complete analysis for FRA:E9Q
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:E9Q has been successfully added to your 
